William K. Heiden

2014

In 2014, William K. Heiden earned a total compensation of $2.7M as Chief Executive Officer at AMAG Pharmaceuticals, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$579,200
Option Awards$838,666
Salary$534,610
Stock Awards$698,378
Other$7,800
Total$2,658,654

Heiden received $838.7K in option awards, accounting for 32% of the total pay in 2014.

Heiden also received $579.2K in non-equity incentive plan, $534.6K in salary, $698.4K in stock awards and $7.8K in other compensation.

Rankings

In 2014, William K. Heiden's compensation ranked 3,419th out of 13,032 executives tracked by ExecPay. In other words, Heiden earned more than 73.8% of executives.

ClassificationRankingPercentile
All
3,419
out of 13,032
74th
Division
Manufacturing
1,209
out of 4,965
76th
Major group
Chemicals And Allied Products
393
out of 1,690
77th
Industry group
Drugs
306
out of 1,369
78th
Industry
Pharmaceutical Preparations
249
out of 1,042
76th
Source: SEC filing on April 20, 2017.

Heiden's colleagues

We found four more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2014.

2014

Frank Thomas

AMAG Pharmaceuticals

Chief Operating Officer

2014

Scott Holmes

AMAG Pharmaceuticals

Chief Accounting Officer

2014

Edward Jordan

AMAG Pharmaceuticals

Senior Vice President of Sales and Marketing

2014

Scott Townsend

AMAG Pharmaceuticals

General Counsel

News

You may also like